Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Dr. Judith Lea SwainIndependent Director | 89,31k | 0,00 | Derivative Exercise and Retained Stock | - | 174,49k | 104,86% |
| 2026-06-03 | Ms. Diane E. SullivanIndependent Director | 89,31k | 0,00 | Derivative Exercise and Retained Stock | - | 126,12k | 242,63% |
| 2026-06-03 | Mr. Christopher J. SobeckiIndependent Director | 89,31k | 0,00 | Derivative Exercise and Retained Stock | - | 293,18k | 43,81% |
| 2026-06-03 | Mr. Ivan H. CheungIndependent Director | 89,31k | 0,00 | Derivative Exercise and Retained Stock | - | 89,31k | - |
| 2026-06-03 | Dr. Samuel L. BarkerIndependent Director | 89,31k | 0,00 | Derivative Exercise and Retained Stock | - | 213,77k | 71,76% |
| 2026-06-03 | Mr. Philippe J. AmouyalIndependent Director | 89,31k | 0,00 | Derivative Exercise and Retained Stock | - | 374,49k | 31,32% |
| 2026-06-03 | Mr. Raymond DebbaneIndependent Chairman of the Board | 89,31k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00M | 4,69% |
| 2026-04-30 | Artal Group S.A.Unternehmen | 20,42M | 0,00 | Derivative Exercise and Retained Stock | - | 175,16M | 13,20% |
| 2026-02-28 | Ms. Wendy E. McDermottSVP of HR | 156,30k | 0,00 | Derivative Exercise and Retained Stock | - | 277,95k | 128,49% |
| 2026-02-28 | Ms. Wendy E. McDermottSVP of HR | -68,11k | 100,12k | Derivative Exercise and Sale | 1,47 | 277,95k | - |
| 2026-02-28 | Ms. Rachel Yap MartensSenior VP of Partnerships & Corporate Strategy | 31,26k | 0,00 | Derivative Exercise and Retained Stock | - | 31,26k | - |
| 2026-02-28 | Ms. Rachel Yap MartensSenior VP of Partnerships & Corporate Strategy | -35,83k | 52,66k | Derivative Exercise and Sale | 1,47 | 31,26k | - |
| 2026-02-28 | Dr. Craig B. GranowitzSenior VP & Chief Medical Officer | 203,18k | 0,00 | Derivative Exercise and Retained Stock | - | 323,43k | 168,96% |
| 2026-02-28 | Dr. Craig B. GranowitzSenior VP & Chief Medical Officer | -109,10k | 160,37k | Derivative Exercise and Sale | 1,47 | 323,43k | - |
| 2026-02-28 | Dr. Suma GopinathanSVP of Discovery | 75,61k | 0,00 | Derivative Exercise and Retained Stock | - | 150,13k | 101,47% |
| 2026-02-28 | Dr. Suma GopinathanSVP of Discovery | -24,34k | 35,78k | Derivative Exercise and Sale | 1,47 | 150,13k | - |
| 2026-02-28 | Ms. Lisa M. DeFrancescoSVP of Investor Relations & Corporate Communications | 78,29k | 0,00 | Derivative Exercise and Retained Stock | - | 93,87k | 502,61% |
| 2026-02-28 | Ms. Lisa M. DeFrancescoSVP of Investor Relations & Corporate Communications | -74,57k | 109,62k | Derivative Exercise and Sale | 1,47 | 93,87k | - |
| 2026-02-28 | Mr. Scott M. CoianteSenior VP & CFO | 105,36k | 0,00 | Derivative Exercise and Retained Stock | - | 105,36k | - |
| 2026-02-28 | Mr. Scott M. CoianteSenior VP & CFO | -54,88k | 80,68k | Derivative Exercise and Sale | 1,47 | 105,36k | - |
| 2026-02-28 | Mr. Brian T. CrumSenior VP, General Counsel & Secretary | 167,99k | 0,00 | Derivative Exercise and Retained Stock | - | 428,80k | 64,41% |
| 2026-02-28 | Mr. Brian T. CrumSenior VP, General Counsel & Secretary | -105,02k | 154,38k | Derivative Exercise and Sale | 1,47 | 428,80k | - |
| 2026-02-28 | Dr. Michael S. ExtonCEO & Director | 298,43k | 0,00 | Derivative Exercise and Retained Stock | - | 298,43k | - |
| 2026-02-28 | Dr. Michael S. ExtonCEO & Director | -204,83k | 301,10k | Derivative Exercise and Sale | 1,47 | 298,43k | - |
| 2026-02-25 | Mr. Raymond DebbaneIndependent Chairman of the Board | 2,00k | 2,98k | Kauf | 1,49 | 1,91M | 0,11% |
| 2026-02-23 | Mr. Raymond DebbaneIndependent Chairman of the Board | 100,00k | 147,00k | Kauf | 1,47 | 1,90M | 5,54% |
| 2026-02-19 | Mr. Raymond DebbaneIndependent Chairman of the Board | 150,00k | 219,76k | Kauf | 1,44 - 1,48 | 1,80M | 9,07% |
| 2026-02-13 | Mr. Raymond DebbaneIndependent Chairman of the Board | 268,50k | 352,89k | Kauf | 1,31 - 1,32 | 1,65M | 19,38% |
| 2026-02-02 | Artal Group S.A.Unternehmen | 1,54M | 2,00M | Kauf | 1,30 | 199,04M | 0,78% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
